IL-10 and IL-4 synergize with TNF-alpha to induce IL-1ra production by human neutrophils

被引:65
作者
Marie, C [1 ]
Pitton, C [1 ]
Fitting, C [1 ]
Cavaillon, JM [1 ]
机构
[1] INST PASTEUR,UNITE IMMUNOALLERGIE,F-75015 PARIS,FRANCE
关键词
IL-1 receptor antagonist; inflammation; lipopolysaccharide; neutrophils; TNF-alpha;
D O I
10.1006/cyto.1996.0021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The anti-inflammatory properties of IL-4, IL-10, IL-13 and TGF-beta are associated with their ability to repress the production of pro-inflammatory cytokines and to favour the release of interleukin-1 receptor antagonist (IL-1ra). Here, we investigate their actions on activated human polymorphonuclear cells (PMN), IL-4 and TGF-beta were able to increase the production of IL-1ra, however only IL-4 were able to further increase IL-1ra production in the presence of LPS. When IL-1ra production by PMN was induced by tumour necrosis factor-alpha (TNF-alpha), IL-10 and IL-4 both amplified its release and its presence as a cell-associated form, In conclusion, IL-10 which was unable to induce IL-1ra by itself or to amplify the LPS-induced production by PMN, was able to increase its release when TNF-alpha, is the triggering signal, IL-4 was active in the different combinations tested; IL-13 and TGF-beta did not further modulate LPS- and TNF-alpha-induced IL-1ra production by PMN. (C) 1996 Academic Press Limited
引用
收藏
页码:147 / 151
页数:5
相关论文
共 29 条
[1]   INTERLEUKIN-1 (IL-1) RECEPTOR ANTAGONIST PREVENTS STAPHYLOCOCCUS-EPIDERMIDIS-INDUCED HYPOTENSION AND REDUCES CIRCULATING LEVELS OF TUMOR-NECROSIS-FACTOR AND IL-1-BETA IN RABBITS [J].
AIURA, K ;
GELFAND, JA ;
BURKE, JF ;
THOMPSON, RC ;
DINARELLO, CA .
INFECTION AND IMMUNITY, 1993, 61 (08) :3342-3350
[2]  
BOGDAN C, 1992, J BIOL CHEM, V267, P23301
[3]  
CASINIRAGGI V, 1995, J IMMUNOL, V154, P2434
[4]   INTERLEUKIN-10 (IL-10) UP-REGULATES IL-1 RECEPTOR ANTAGONIST PRODUCTION FROM LIPOPOLYSACCHARIDE-STIMULATED HUMAN POLYMORPHONUCLEAR LEUKOCYTES BY DELAYING MESSENGER-RNA DEGRADATION [J].
CASSATELLA, MA ;
MEDA, L ;
GASPERINI, S ;
CALZETTI, F ;
BONORA, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (05) :1695-1699
[5]  
CHOMARAT P, 1995, IMMUNOLOGY, V154, P1432
[6]  
DINARELLO CA, 1991, BLOOD, V77, P1627
[7]  
FISHER E, 1992, BLOOD, V79, P2196
[8]   PRODUCTION OF INTERLEUKIN-1-RECEPTOR ANTAGONIST DURING EXPERIMENTAL ENDOTOXEMIA [J].
GRANOWITZ, EV ;
SANTOS, AA ;
POUTSIAKA, DD ;
CANNON, JG ;
WILMORE, DW ;
WOLFF, SM ;
DINARELLO, CA .
LANCET, 1991, 338 (8780) :1423-1424
[9]   INTERLEUKIN-1 RECEPTOR ANTAGONIST IN NORMAL AND PSORIATIC EPIDERMIS [J].
HAMMERBERG, C ;
AREND, WP ;
FISHER, GJ ;
CHAN, LS ;
BERGER, AE ;
HASKILL, JS ;
VOORHEES, JJ ;
COOPER, KD .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (02) :571-583
[10]   IL-4 AND IL-13 EXHIBIT COMPARABLE ABILITIES TO REDUCE PYROGEN-INDUCED EXPRESSION OF PROCOAGULANT ACTIVITY IN ENDOTHELIAL-CELLS AND MONOCYTES [J].
HERBERT, JM ;
SAVI, P ;
LAPLACE, MC ;
LALE, A ;
DOL, F ;
DUMAS, A ;
LABIT, C ;
MINTY, A .
FEBS LETTERS, 1993, 328 (03) :268-270